News
TEVA
28.46
+0.18%
0.05
Teva Pharmaceuticals Initiated at Sector Outperform by Scotiabank
Dow Jones · 16h ago
Teva Pharmaceuticals Price Target Announced at $35.00/Share by Scotiabank
Dow Jones · 16h ago
Scotiabank Initiates Coverage On Teva Pharmaceutical Indus with Sector Outperform Rating, Announces Price Target of $35
Benzinga · 16h ago
Can Galafold Continue to Drive Amicus' Top Line in 2026?
NASDAQ · 16h ago
Teva Pharmaceutical (TEVA) Gets a Buy from Piper Sandler
TipRanks · 18h ago
Teva initiated with an Outperform at Scotiabank
TipRanks · 1d ago
Mark Cuban calls for end to generic drug application fees to boost domestic manufacturing
Seeking Alpha · 1d ago
Teva (NYSE:TEVA) Valuation Check After Strong Q3, Margin Targets and Deleveraging Drive a Sharp Share Price Rebound
Simply Wall St · 1d ago
Catalyst: Firdapse Cliff Deferred, But Capital Allocation Still An Issue (Upgrade)
Seeking Alpha · 2d ago
Teva sees cash flow ‘probably around’ $2.7B in 2027
TipRanks · 2d ago
The Bull Case For Teva (TEVA) Could Change Following Launch Of Teva Rise Innovation Platform
Simply Wall St · 3d ago
Noteworthy ETF Inflows: IEFA, SPOT, SE, TEVA
NASDAQ · 3d ago
BUZZ-Amneal rises after US FDA nod for generic asthma inhaler
Reuters · 3d ago
ValuEngine Weekly Market Summary And Commentary
Seeking Alpha · 3d ago
Teva Pharmaceutical Director Makes a Bold Stock Sale
TipRanks · 4d ago
Teva Director Roberto Mignone Reports Disposal of Common Shares
Reuters · 4d ago
Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), LENZ Therapeutics (LENZ) and Teva Pharmaceutical (TEVA)
TipRanks · 4d ago
Weekly Report: what happened at TEVA last week (1124-1128)?
Weekly Report · 4d ago
30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 3 Biotech Stocks
The Motley Fool · 5d ago
Trump Weekly: White House postpones healthcare proposal after backlash
TipRanks · 11/28 16:00
More
Webull provides a variety of real-time TEVA stock news. You can receive the latest news about Teva Pharm through multiple platforms. This information may help you make smarter investment decisions.
About TEVA
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.